ResearchAndMarkets.com has added the "Precision Medicine Collaboration and Licensing Deals 2019-2026" report to its offering, presenting a structured review of more than 1,350 precision medicine partnership and licensing agreements. The publication is positioned as a benchmark for dealmaking in a field shaped by diagnostics, data, and targeted therapies, with analysis spanning upfront payments, milestones, royalties, partner behavior, and contract structure. It also includes a searchable deal directory and access to SEC-filed agreements, giving users a closer view of how rights, responsibilities, payment triggers, and contractual protections are allocated across precision medicine partnerships.